CIK: 1213709 - Address: C/O Pharmacyte Biotech, Inc., 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV 89169
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/31/23 08:32
5/30/23
XWELXwell, Inc.DEPerSvPerSvPersonal ServicesWeinstein RobertNYDP60.247002519156D
5/30/23 08:34
5/26/23
XWELXwell, Inc.DEPerSvPerSvPersonal ServicesWeinstein RobertNYDP60.250002523131D
12/20/22 20:02
12/16/22
SNPXSynaptogenix, Inc.DEHealthDrugPharmaceutical PreparationsWeinstein RobertNYOCFOS-321.170-27-4533D
4/22/22 19:59
4/20/22
XSPAXpresspa Group, Inc.DEPerSvPerSvPersonal ServicesWeinstein RobertNYDS-481.060-45-30106D
1/21/22 17:08
1/19/22
XSPAXpresspa Group, Inc.DEPerSvPerSvPersonal ServicesWeinstein RobertNYDS-701.560-45-27120D
10/22/21 16:15
9/20/21
XSPAXpresspa Group, Inc.DEPerSvPerSvPersonal ServicesWeinstein RobertNYDS-901.430-63-28165D
4/4/08 19:12
4/2/08
XCRXcorporeal, Inc.DEHealthElcMdElectromedical & ElectrotheraWeinstein RobertCAOCFOP301.50020New20D
9/3/04 15:41
9/1/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOM.d88.30010D
9/3/04 15:41
9/1/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOS.d-2221.730-1-1000D
6/3/04 18:21
6/1/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOM.d218.30030D
6/3/04 18:21
6/1/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOS.dm-4618.410-3-1000D
4/5/04 17:27
4/1/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOM.d428.30050D
4/5/04 17:27
4/1/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOS.d-9719.380-5-1000D
2/3/04 18:35
2/2/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOM.d428.30050D
2/3/04 18:35
2/2/04
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOS.d-9118.120-5-1000D
12/3/03 14:54
12/1/03
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOM.d428.30050D
12/3/03 14:54
12/1/03
ABRXAble Laboratories IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWeinstein RobertNJOCFOS.d-9318.610-5-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact